NDC0007-0841-01: CIPROFLOXACIN HYDROCHLORIDE OPHT.
CIPROFLOXACIN HYDROCHLORIDE OPHT. Key specifications include administration: OPHTHALMIC, features_provided: STERILE, primary_container_type: TUBE, primary_container_content_quantity: 3.500 GRAMS G, active_medicament_medicinal_strength: 3.330 GRAMS CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT G, part_name_assigned_by_controlling_agency: CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC OINTMENT 3.5GM TUBE. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-476-8686, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | OPHTHALMIC |
| features_provided | STERILE |
| primary_container_type | TUBE |
| primary_container_content_quantity | 3.500 GRAMS G |
| active_medicament_medicinal_strength | 3.330 GRAMS CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT G |
| part_name_assigned_by_controlling_agency | CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC OINTMENT 3.5GM TUBE |
| NSN | 6505-01-476-8686 |
| ADMINISTRATION | OPHTHALMIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 3.500 GRAMS G |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | TUBE |
| SPECIAL FEATURES | EACH GRAM OF CILOXAN OINTMENT CONTAINS CIPROFLOXACIN HCL 3.33 MG EQUIVALENT TO 3 MG BASE; CILOXAN OPHTHALMIC OINTMENT IS A SYNTHETIC, STERILE, MULTIPLE DOSE ANTIMICROBIAL FOR TOPICAL USE, NOT FOR INJECTION INTO THE EYE;INDICATED FOR THE TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF MICROORGANISMS(AEROBIC GRAM POSITIVE AND AEROBIC GRAM NEGATIVE); STORE AT 2 TO 25 DEG C DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC OINTMENT 3.5GM TUBE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.330 GRAMS CIPROFLOXACIN HYDROCHLORIDE ACTIVE INGREDIENT G |